Video

Dr. Lynch on the Goals of Bristol-Myers Squibb

Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses goals at Bristol-Myers Squibb.

Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses the goals of Bristol-Myers Squibb.

Lynch believes that physicians are motivated by 2 things—the desire to help patients and the sense of mission of the hospital, doctors, and nurses. These caregivers are working together for a common cause. Bristol-Myers Squibb embodies that same sense of a common cause, explains Lynch. The common cause centers around the idea of scientists, regulatory agencies, and clinical trial developers working together to create better medicine, states Lynch.

Over the next several years, Lynch says that his goals are to improve the ability of these medicines to make a difference in improving the cure rate for cancers and help people live longer, he says.

Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center